Clinical Trial: Post-bypass Prophylactic IVIG in Infants and Neonates

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Intravenous Immunoglobulin for Early Prevention of Cardiopulmonary Bypass Induced Hypogammaglobulinemia in Infants and Neonates

Brief Summary: The purpose of this study protocol is to determine if administering Intravenous Immunoglobulin (IVIG) for treatment of cardiopulmonary bypass (CPB) induced hypogammaglobulinemia in the early post-operative period can impact post-surgical outcomes (i.e., infection, fluid overload, and associated morbidities).